Medtronic Resolute Onyx 2.0 mm Clinical Study
Public ClinicalTrials.gov record NCT02412501. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this trial is to assess the safety and efficacy of the Resolute Onyx Zotarolimus-Eluting Coronary Stent System for the treatment of de novo lesions in native coronary arteries that allows the use of a 2.0 mm diameter stent.
Study identification
- NCT ID
- NCT02412501
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 101 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 6, 2015 (Actual)
- Primary completion
- Feb 13, 2017 (Actual)
- Completion
- Feb 21, 2019 (Actual)
- Last update posted
- Jul 2, 2019
2015 – 2019
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scripps Green Hospital | La Jolla | California | 92037 | — |
| Morton Plant Hospital | Clearwater | Florida | 33756 | — |
| Saint John's Hospital | Springfield | Illinois | 62701 | — |
| St. Vincent Heart Center of Indiana | Indianapolis | Indiana | 46290 | — |
| Barnes Jewish University | St Louis | Missouri | 63110 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| The Mount Sinai Medical Center | New York | New York | 10029 | — |
| Saint Francis Hospital | Roslyn | New York | 11576 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Sanford Medical Center | Fargo | North Dakota | 58102 | — |
| University Hospitals Elyria Medical Center | Elyria | Ohio | 44035 | — |
| Geisinger Medical Center | Danville | Pennsylvania | 17822 | — |
| Lankenau Medical Center | Wynnewood | Pennsylvania | 19096 | — |
| AnMed Health Medical Center | Anderson | South Carolina | 29621 | — |
| Centennial Medical Center | Nashville | Tennessee | 37205 | — |
| Dallas VA Medical Center | Dallas | Texas | 75216 | — |
| East Texas Medical Center | Tyler | Texas | 75701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02412501, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2019 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02412501 live on ClinicalTrials.gov.